Company Filing History:
Years Active: 2009-2011
Title: Kathleen Schell: Innovator in Functional Genomics
Introduction
Kathleen Schell is a prominent inventor based in Madison, Wisconsin. She has made significant contributions to the field of functional genomics, particularly in the area of white blood cell assays. With a total of two patents to her name, her work has the potential to advance medical diagnostics and therapeutic strategies.
Latest Patents
Kathleen's latest patents include a "Functional genomic pore assay for mixed cell populations" and a "White blood cell functional assay." The first patent provides a method for assaying nucleotide receptor P2X pore activity in white blood cells within a mixed cell sample. This involves labeling the white blood cells, depolarizing them, and analyzing dye uptake to quantify P2X pore activity. The second patent outlines a rapid method for assaying nucleotide receptor P2X pore activity in white blood cells contained within a blood sample, utilizing similar steps to achieve accurate quantification.
Career Highlights
Kathleen Schell is associated with the Wisconsin Alumni Research Foundation, where she continues to innovate and contribute to scientific research. Her work is instrumental in enhancing our understanding of white blood cell functionality and its implications for health.
Collaborations
Some of her notable coworkers include Loren C. Denlinger and Kirk Jeffrey Hogan, who collaborate with her on various research initiatives.
Conclusion
Kathleen Schell's innovative work in functional genomics and her patents reflect her dedication to advancing medical science. Her contributions are paving the way for improved diagnostic methods and therapeutic approaches in healthcare.